New immunosuppressive therapies in renal transplantation: monoclonal antibodies.


Remarkable advances in understanding the mechanisms of immune recognition and allograft rejection have been made in the past few years, leading to the development of innovative immunosuppressive strategies in the field of renal transplantation. Monoclonal antibodies (mAbs) have emerged as a new class of immunosuppressive agents, which appear to be effective… (More)


  • Presentations referencing similar topics